Debjani Banerjee

555 total citations
13 papers, 495 citations indexed

About

Debjani Banerjee is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Debjani Banerjee has authored 13 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 7 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Debjani Banerjee's work include Synthesis and biological activity (5 papers), Tuberculosis Research and Epidemiology (4 papers) and HIV/AIDS drug development and treatment (4 papers). Debjani Banerjee is often cited by papers focused on Synthesis and biological activity (5 papers), Tuberculosis Research and Epidemiology (4 papers) and HIV/AIDS drug development and treatment (4 papers). Debjani Banerjee collaborates with scholars based in India. Debjani Banerjee's co-authors include Dharmarajan Sriram, Perumal Yogeeswari, Pritesh Bhat, Subbu Perumal, Raju Suresh Kumar, Michael Rajesh Stephen, Palaniappan Senthilkumar, Murugesan Dinakaran, Valakunja Nagaraja and Arnab China and has published in prestigious journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Debjani Banerjee

13 papers receiving 476 citations

Peers

Debjani Banerjee
Debjani Banerjee
Citations per year, relative to Debjani Banerjee Debjani Banerjee (= 1×) peers Murugesan Dinakaran

Countries citing papers authored by Debjani Banerjee

Since Specialization
Citations

This map shows the geographic impact of Debjani Banerjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debjani Banerjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debjani Banerjee more than expected).

Fields of papers citing papers by Debjani Banerjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debjani Banerjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debjani Banerjee. The network helps show where Debjani Banerjee may publish in the future.

Co-authorship network of co-authors of Debjani Banerjee

This figure shows the co-authorship network connecting the top 25 collaborators of Debjani Banerjee. A scholar is included among the top collaborators of Debjani Banerjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debjani Banerjee. Debjani Banerjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sriram, Dharmarajan, et al.. (2011). Novel antitubercular diallyl/dibenzylthiosemicarbazones endowed with high activity toward multi-drug-resistant tuberculosis. Medicinal Chemistry Research. 21(6). 810–815. 6 indexed citations
2.
Sriram, Dharmarajan, Perumal Yogeeswari, Palaniappan Senthilkumar, et al.. (2010). Synthesis and Antimycobacterial Evaluation of Novel Phthalazin‐4‐ylacetamides Against log‐ and Starved Phase Cultures. Chemical Biology & Drug Design. 75(4). 381–391. 26 indexed citations
3.
Banerjee, Debjani, et al.. (2010). Novel isatinyl thiosemicarbazones derivatives as potential molecule to combat HIV-TB co-infection. European Journal of Medicinal Chemistry. 46(1). 106–121. 117 indexed citations
4.
5.
Sriram, Dharmarajan, et al.. (2009). Discovery of novel antitubercular 2,10-dihydro-4aH-chromeno[3,2-c]pyridin-3-yl derivatives. European Journal of Medicinal Chemistry. 45(1). 120–123. 31 indexed citations
6.
Kumar, Raju Suresh, Michael Rajesh Stephen, Subbu Perumal, et al.. (2009). Novel three-component domino reactions of ketones, isatin and amino acids: Synthesis and discovery of antimycobacterial activity of highly functionalised novel dispiropyrrolidines. European Journal of Medicinal Chemistry. 45(1). 411–422. 129 indexed citations
7.
Perumal, Subbu, et al.. (2009). l-Proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines. European Journal of Medicinal Chemistry. 44(12). 4978–4984. 22 indexed citations
8.
Sriram, Dharmarajan, et al.. (2008). 5-Nitrofuran-2-yl derivatives: Synthesis and inhibitory activities against growing and dormant mycobacterium species. Bioorganic & Medicinal Chemistry Letters. 19(4). 1152–1154. 38 indexed citations
9.
Sriram, Dharmarajan, Debjani Banerjee, & Perumal Yogeeswari. (2008). Efavirenz Mannich bases: Synthesis, anti-HIV and antitubercular activities. Journal of Enzyme Inhibition and Medicinal Chemistry. 24(1). 1–5. 43 indexed citations
10.
Senthilkumar, Palaniappan, Murugesan Dinakaran, Debjani Banerjee, et al.. (2007). Synthesis and antimycobacterial evaluation of newer 1-cyclopropyl-1,4-dihydro-6-fluoro-7-(substituted secondary amino)-8-methoxy-5-(sub)-4-oxoquinoline-3-carboxylic acids. Bioorganic & Medicinal Chemistry. 16(5). 2558–2569. 20 indexed citations
11.
Sriram, Dharmarajan, et al.. (2007). N-Hydroxythiosemicarbazones: Synthesis and in vitro antitubercular activity. Bioorganic & Medicinal Chemistry Letters. 17(7). 1888–1891. 23 indexed citations
12.
13.
Sriram, Dharmarajan, et al.. (2006). Newer tetracycline derivatives: Synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase. Bioorganic & Medicinal Chemistry Letters. 17(8). 2372–2375. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026